Association of SGLT2 Inhibitors With Risk of Atrial Fibrillation and Stroke in Patients With and Without Type 2 Diabetes: A Systemic Review and Meta-Analysis of Randomized Controlled Trials

Sodium-glucose cotransporter 2 (SGLT2) inhibitors have well-documented effects on reducing hospitalization for heart failure and cardiovascular mortality, although the effect on atrial fibrillation (AF) has not been comprehensively investigated. Therefore, we performed a meta-analysis to assess the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Ru-Jie, Wang, Yue, Tang, Jun-Nan, Duan, Jie-Ying, Yuan, Ming-Yue, Zhang, Jin-Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Journal of Cardiovascular Pharmacology 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895972/
https://www.ncbi.nlm.nih.gov/pubmed/34813574
http://dx.doi.org/10.1097/FJC.0000000000001183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895972/
https://www.ncbi.nlm.nih.gov/pubmed/34813574
http://dx.doi.org/10.1097/FJC.0000000000001183

Ejemplares similares